News
In an SEC filing, BMS says that it has decided that parting with Otezla (apremilast) – which earned $1.6 billion for Celgene last year – was a reasonable price to pay to bring the merger to ...
The usual maintenance dosage of Otezla (apremilast) is two 30-mg doses per day. It’s important to take the Otezla dosage your doctor prescribes. Otezla belongs to a class of drugs called disease ...
A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...
The European Commission (EC) has licensed Celgene's Otezla (apremilast) for the treatment of moderate-to-severe chronic plaque psoriasis and alone or in combination with Disease Modifying ...
Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio ...
For tolerability analysis, the investigators used an additional safety reference arm related to apremilast, a psoriatic ...
Apremilast treatment for 1 year significantly reduced abdominal fat and maintained lean mass in patients with psoriatic arthritis (PsA), alongside notable improvements in disease activity. Those ...
2mon
Medpage Today on MSNTYK2 Inhibitor Scores Two Wins Outside Plaque PsoriasisInvestigators randomized 729 patients 3:3:1 to deucravacitinib, placebo, or an apremilast (Otezla) safety reference group.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results